✦ LIBER ✦

REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT

✍ Scribed by van Holten-Verzantvoort, A.Th.; Bijvoet, O.L.M.; Hermans, J.; Harinck, H.I.J.; Elte, J.W.F.; Beex, L.V.A.M.; Cleton, F.J.; Kroon, H.M.; Vermey, P.; Neijt, J.P.; Blijham, G.

Book ID: 122023157
Publisher: The Lancet
Year: 1987
Tongue: English
Weight: 376 KB
Volume: 330
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(87)92555-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zoledronic acid has long-term efficacy i

Zoledronic acid has long-term efficacy in reducing skeletal complications in patients with bone metastases from breast cancer

✍ R Coleman; L Rosen; M Zheng 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 357 KB

A case of osteonecrosis of the jaw in a

A case of osteonecrosis of the jaw in a breast cancer patient with bone metastases receiving long-term treatment with bisphosphonates

✍ Yukako Mouri; Miwa Yoshida; Shogo Nakano; Kyoko Yorozuya; Kimihito Fujii; Takash 📂 Article 📅 2008 🏛 Springer Japan 🌐 English ⚖ 175 KB

Long-term safety of oral ibandronate in

Long-term safety of oral ibandronate in patients with skeletal metastases from breast cancer: 4-year follow-up data

✍ D Cameron; R Murray; D Tripathy; B Bergström 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 164 KB

P-676 Long-term therapy with zoledronic

P-676 Long-term therapy with zoledronic acid is effective and safe in reducing the risk of skeletal complications in patients with bone metastases from non-small cell lung cancer

✍ Bukowski, Ronald; Rosen, Lee S.; Gordon, David; Tchekmedyian, Simon; Hirsh, Vera 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 365 KB